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1. INTRODUCTION 
Ethanol is the most frequently abused drug in the United States and Western 
countries, including in Estonia (U.S. Department of Health and Human Ser-
vices, 2007; Falk et al., 2008). Increasing alcohol consumption is accompanied 
by the growing problem of alcohol consumption among children and adoles-
cents (Madu et al., 2003; Meyer et al., 2003; Meyer et al., 2008; Schöberl et al., 
2008; Sutherland et al., 1998; Woolfenden et al., 2002). The International Self-
Reported Delinquency Study-2, or ISRD-2, showed that on average 53% of 
Estonian 15–16-year-old adolescents had had at least one heavy drinking 
episode in the past 30 days (Markina et al., 2007). As per WHO, heavy episodic 
drinking is defined as the proportion of adults (15+ years) who have had at least 
60 gram or more of pure alcohol on at least one occasion in the past 30 days 
(WHO, 2014). Drinking alcohol at a young age is a risk factor for alcohol 
addiction later in life (Patrick et al., 2013), and is connected with problems in 
school (Latvala et al., 2014), binge drinking (White et al., 2013), tobacco addic-
tion (Hughes et al., 2015; Lee et al., 2014), illegal drug use (Harris et al., 2014), 
and risky sexual behaviours (de Looze et al., 2015; Monk et al., 2014; Hage-
mann et al., 2013). Alcohol is also linked to violent crimes (Archimi et al., 
2014; Green et al., 2011), suicides (Lahti et al., 2014; Kaplan et al., 2013; 
Holmgren and Jones, 2010; Flensborg-Madsen et al., 2009), and accidental 
deaths (Weiss et al., 2014; Estonian Institute of Economic Research Yearbook, 
2013; Mørland et al., 2011; Koski et al., 2007).  
As the frequency and amount of alcohol consumption by children and ad-
olescents has gradually increased, medical personnel at hospitals have to be pre-
pared for an increased workload due to the medical problems caused by acute 
alcohol intoxication (AAI). Biochemical tests, such as glucose, lactate and 
electrolytes levels in plasma or serum are a part of clinical practise to evaluate 
the clinical condition of patients with AAI. There have been very few studies 
about the relationships between biochemical and hormonal changes in the blood 
of children hospitalised with AAI. The aim of the current study was to describe 
clinical, mental and physical signs in children with different severity of AAI 
levels. In addition, to investigate the prevalence of changes in plasma levels of 
glucose, lactate, potassium and sodium in children hospitalized with AAI, and 
their relationships with plasma cortisol, testosterone, estradiol and progesterone 
levels.  
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2. REVIEW OF LITERATURE  
2.1. Alcohol consumption 
2.1.1. In the world 
Alcoholic beverages are available throughout the world. The level of alcohol 
consumption is conventionally reported in terms of annual per capita consump-
tion of pure alcohol (100%) in litres (ACCAL). The mean worldwide ACCAL 
in 2005 was 6.13 litres consumed by every person aged 15 years or older, rang-
ing from more than 12.5 litres in the developed world (mostly the  Northern 
Hemisphere, Argentina, Australia and New Zealand) to  under 2.5 litres  in 
North and sub-Saharan Africa, the Eastern Mediterranean region, and South-
East Asia regions, but worldwide, recorded consumption has been stable at 4.3–
4.7 litres of pure alcohol per capita since 1990 (WHO; 2011). There is a gender 
difference in ACCAL: from 2.3 to 62.1 litres in males and from 0.2 to 33.0 
litres in females (WHO, 2011). 
According to the Summary Health Statistics for United States, 52% of adults 
aged 18 and over were regular drinkers, 13% were currently infrequent drinkers, 
6% were formerly regular drinkers, and 8% were formerly infrequent drinkers 
(National Health Interview Survey, 2012). The same study reported that 60% of 
men and 44% of women were currently regular drinkers. 
 
 
2.1.2. In Estonia 
The total (recorded and unrecorded) consumption of alcohol in Estonia in 2005 
was 22.00 litres per capita, 36.1 litres for men and 12.2 litres for women. The 
alcohol consumed was mostly in the form of spirits and beer in 2005 (WHO, 
2011). Over the next eight years, the total consumption of alcohol in Estonia de-
creased to 11.9 litres per capita in 2013. The largest amount of alcohol con-
sumed in 2013 was beer and light alcoholic drinks, whereas the consumption of 
strong alcoholic beverages decreased over the period of 2005–2013 (Estonian 
Institute of Economic Research, 2014). Inhabitants´ assessments of their own 
alcohol consumption in 2006–2012 showed that 15.3% of respondents did not 
use alcohol at all, 55.3% drank a little, 26.7% drank moderately and 2.7% drank 
a lot (Estonian Institute of Economic Research, 2013).  
 
 
2.1.3. Among children and adolescents 
In the European School Survey Project on Alcohol and Other Drugs, 41% of all 
males between 15 and 16 years of age and 38% of all females at the same age 
interviewed reported five drinks or more on the same occasion during the past 
30 days (European School Survey Project on Alcohol and Other Drugs, 2011). 
Among a teenage population evaluated in Australia, 29% of the subjects re-
ported drinking to the point of drunkenness (Williams et al., 2000). About 86% 
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of 13 to 16-year-old adolescents in Estonia had consumed alcohol in their life-
time and the average age at initial alcohol consumption was 11.3 years in girls, 
and 10.7 years in boys (Markina et al., 2007). Similar results have been reported 
in different European countries. For example, 78% of Polish children declared 
consumption of alcohol in the last 12 months (Kaminska et al., 2012). Accord-
ing to the Health Behaviour in School-aged Children (HBSC) study, the preval-
ence of drunkenness increased significantly between ages 11 and 15 for boys 
and girls in European countries. Totally, 2% of 11-year-old girls and 5% of 
boys (1% of girls and 2% of boys in Estonia) and 17% of 15-year-old girls and 
25% boys (13% of girls and 20% of boys in Estonia) had drunk alcohol at least 
once a week. The same study reported that 1% of 11-year-old girls and 3% of 
boys (1% of girls and 1% of boys in Estonia) and 29% of 15-year-old girls and 
34% of boys (42% of girls and 48% of boys in Estonia) had been drunk at least 
twice (Currie et al., 2012).  
 
 
2.2. Alcohol pharmacokinetics and pharmacodynamics 
Acute alcohol intoxication (AAI) is a clinically harmful condition that follows 
the ingestion of a large amount of ethanol.   
Ethanol (CH3CH2OH) is an easily water-divided compound that rapidly 
crosses cell membranes. Ethanol is rapidly absorbed in the stomach and in the 
duodenum, while only a small percentage occurs in the remaining intestinal 
tract. The consumption of alcohol together with or after a meal leads to a slower 
rate of absorption because stomach emptying is delayed and the maximal con-
centration (Cmax) is lower and occurs later compared with a drinking on an 
empty stomach (Jones et al., 1994; Klockhoff et al., 2002). Blood from the 
gastrointestinal tract goes to the portal vein, where the alcohol is transported 
through the liver, and then on to the heart and the systemic circulation. The 
metabolism of alcohol occurs mainly through the action of enzymes located in 
the liver, and small amounts are metabolized also in the mucosa of the stomach. 
After absorption, ethanol is distributed into the water compartment of the body. 
The concentration of alcohol in the organs and tissues after reaching equilib-
rium depends primarily on the water content in these tissues (Endres et al., 
1994). Body fluids such as sweat, saliva and urine, which are almost 100% 
water, contain a higher concentration of ethanol than whole blood, which is 
80% water (Jones, 2006; Jones, 1993). Plasma and serum with a water content 
of 92% hold a higher concentration of alcohol than blood (Iffland et al., 1999). 
The majority of bloodstream alcohol (95–98%) is eliminated from the body by 
oxidative metabolism (Lieber et al., 2000), primarily by the liver. Metabolism 
of ethanol occurs via two pathways. The first pathway comprises two steps.  
The first step is metabolism to acetaldehyde, catalysed by the enzyme alcohol 
dehydrogenase (ADH), which takes place in the cytosol of the liver. The second 
step to acetate, catalysed by the aldehyde dehydrogenase (ALDH), takes place 
in mitochondria. In ADH-mediated oxidation of alcohol, hydrogen is transferred 
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from the substrate to the cofactor nicotinamide adenine dinucleotide oxidized 
form (NAD), converting it to nicotinamide adenine dinucleotide reduced form 
(NADH), and acetaldehyde is produced. Thus, ethanol consumption leads to an 
accumulation of NADH. This high concentration of NADH inhibits gluconeo-
genesis by preventing the oxidation of lactate to pyruvate.  The altered redox 
state, in turn, is responsible for a variety of biochemical and hormonal disturb-
ances. About 3–5% of the alcohol is excreted unchanged in breath, urine, and 
sweat (Jones, 2006). Less than 1% of the amount of alcohol undergoes conjuga-
tion by ethyl glucuronide in the gastric mucosa or in the liver.   
 
Figure 1.  Diagram of alcohol metabolism.  
 
 
The second pathway for ethanol metabolism is called the ethanol-inducible mi-
crosomal ethanol-oxidizing system (MEOS), and about 10% of alcohol is meta-
bolized by the enzyme cytochrome P4502E1 (CYP2E1). This pathway uses 
oxygen, and therefore generates free radicals that damage tissues (Berg et al., 
2002). The CYP2E1 has a higher Michelis-Menten constant (km) for oxidation of 
ethanol, and therefore comes into play when blood alcohol concentration (BAC) 
reaches higher concentration, as in heavy drinkers and alcoholics (Figure 1). 
The other effect is that liver mitochondria can convert acetate into acetyl CoA 
in a reaction requiring adenosine triphosphate (ATP). Further processing of the 
acetyl CoA by the citric acid cycle is blocked, as NADH inhibits two regulatory 
enzymes – isocitrate dehydrogenase and α-ketoglutarate dehydrogenase. The 
result of accumulation of acetyl CoA is forming and releasing of ketone bodies 
into the blood, exacerbating the acidic condition already resulting from the high 
lactate concentration. The processing of the acetate in the liver becomes 
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inefficient, leading to a build-up of acetaldehyde, which forms covalent bonds 
with many important proteins, impairing protein function (Berg et al., 2002).  
 
 
2.3. Clinical signs of alcohol intoxication 
2.3.1 Clinical features and symptoms of 
 acute alcohol intoxication in adults  
The effects of alcohol on the individual depend on the amount of alcohol 
ingested, the speed of drinking, the rate of increase in BAC, and previous 
experience with drinking (tolerance).  
Clinical signs and symptoms of acute alcohol intoxication have been well 
studied in adults, and the Diagnostic and Statistical Manual of Mental Disorders 
IV (DSM-4) published by the American Psychiatric Association for the dia-
gnosis of AAI is used in everyday work (Diagnostic and Statistical Manual of 
Mental Disorders 4th edition, 1994). Disturbed consciousness or memory, 
slurred speech, imbalance, aggressiveness, or euphoria may be a sign of AAI. 
Somnolence, stupor, disorientation, and disturbance of balance are frequent and 
well-recognised CNS symptoms of alcohol intoxication.  
It has been found that the psychomotor disturbances in adults with AAI with 
similar drinking customs are similar at different age groups (Karch, 1998). 
Studied men who received ethanol, reliably detected its effects when plasma 
ethanol levels reached 32 mg/dl, but only the subjects who received the high 
dose reported episodes of intense well-being or euphoria (Morgan et al., 2001). 
Ethanol-induced euphoria occurred while plasma ethanol levels were rapidly 
rising (Di Chiara et al., 1996; Lukas et al., 1986).  
Measurements of the pulse, frequency of breath, blood pressure, and body 
temperature are part of the physical examination of a patient, but they are not 
specific to estimating the level of drunkenness. Some studies have found that the 
pulse of alcohol intoxicated people is often accelerated (Brunelle et al., 2004; 
Ryan et al., 2002), but can also occasionally be slower than normal (Brvar et al., 
2009). Blood pressure can express a similar tendency – from hypotension in rare 
cases (Wilson et al., 2007) to hypertension in common cases (Puddey and Beilin, 
2006; Reims et al., 2004; Spencer et al., 1999). However, one study has reported 
the decrease of blood pressure after acute alcohol consumption and thereafter 
increase during 24 hours (Barden et al., 2013). 
The breathing frequency is related to the intoxication level and lactate level 
in plasma – an increased lactate level leads to acidosis and this in turn to an 
increased breathing rate. Body temperature is often influenced by the outside 
temperature: the hazard to hypothermia is greater in cold weather (Bouthoorn et 
al., 2010; Kornfält and Johansson, 2010; Devaney et al., 2003). Many studies 
describe good correlations between CNS symptoms and the blood alcohol con-
centration (BAC) in adults (McKnight et al., 1997; Zoethout et al., 2011), but 
there is insufficient information about similar studies in children (Lamminpää, 
1994). 
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2.3.2 Clinical features and symptoms of AAI in children  
Although there are a lot of studies related to different aspects of AAI in chil-
dren, few have looked at the clinical signs and symptoms of AAI (Bouthoorn et 
al., 2011; Weinberg et al., 2006). Bouthoorn et al. retrospectively studied that 
reduced consciousness (45%) and hypothermia (43.1%) were the most common 
clinical findings of AAI children in the hospital (Bouthoorn et al., 2011). The 
psychomotor disturbances in children varies greatly between different age 
groups due to the variances in the maturation of the body. Acute alcohol intox-
ication is worse in younger children (Minera and Robinson, 2014; Fong and 
Muller, 2014; Palano et al., 2007), because of the faster rise in the blood alcohol 
concentration and the development of pronounced euphoria. 
Children’s studies have usually described children with serious alcohol in-
toxication without the comparable groups of mildly or moderately intoxicated 
children. Alcohol is distributed throughout the water in the body without bind-
ing to plasma proteins. This property causes the gender difference i.e. as fe-
males with the same body mass have less water content than males, they 
develop higher blood alcohol concentration than men (Mirand and Welte, 
1994). In younger children, the entire water content of the body exceeds or is 
similar to the adult man’s water content, calculated with Mellits-Cheek formula 
(http://www.medcalc.com/tbw.html). At the same blood alcohol concentration, 
the child has much more alcohol per body weight than an adult has and there-
fore has much more severe alcohol intoxication.  
In the emergency department, the paediatrician on-call should diagnose and 
treat the AAI in the first instance to avoid complications. Assessment of the 
intoxication level by clinical signs can help to determine treatment tactics, but 
the clinical assessment of drunken children is not an easy task as there are no 
objective criteria to determine the alcohol intoxication level: it is often 
subjective and depends on the experience of the on-call physician.  
 
 
2.4. Ratio of SAC/BAC 
The clinical signs of AAI in adults have been compared with alcohol concen-
trations in different biological fluids, such as in serum, plasma or blood 
(Dubowski, 1980; Vonghia et al., 2008; Wright, 1991), but there are only a few 
such studies done involving children (Bouthoorn et al., 2011). Alcohol concen-
tration is often measured in serum or plasma in hospitals; however, in legal 
cases, serum or plasma ethanol concentrations have to be converted into blood 
alcohol concentration. Therefore, the correlations between the clinical signs of 
AAI and SAC or BAC are often not comparable, as the SAC is usually slightly 
higher than the BAC (Shajani et al., 1989; Winek et al., 1987). The SAC to 
BAC ratio in adults is between 1.12:1 and 1.18:1 (Barnhill et al., 2007). To our 
best knowledge, no such information is available for children. 
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2.5. Biochemical disturbances in serum  
of patients with AAI 
The different reports have shown that acidosis, including lactic acidosis (Höjer, 
1996; Zehtabchi et al., 2005), hypokalaemia (Elisaf et al., 2002; Reid et al., 
2012), hypernatraemia (Lamminpää et al., 1991; Rauchenzauner et al., 2005) 
and hypoglycaemia (Madsen, 1990; Hammerstedt et al., 2011) or hyper-
glycaemia (Pach et al., 2007) do occur in adults or patients with AAI. There are 
also studies that have looked at the biochemical changes during AAI in children 
(Bradford, 1984; Lamminpää et al., 1993; Lamminpää, 1994; Lamminpää, 
1995; Marchi et al., 2003; Roy et al., 2003). 
 
 
2.5.1. Glucose and lactate 
The study performed in 4005 non-diabetic intoxicated adults has shown that 
ethanol was the reason of hypoglycaemia in 20.1 to 40% of patients (Lionte et 
al., 2004). Hypoglycemia is due in part to the block of hepatic gluconeogenesis 
by ethanol, again as a consequence of the increased NADH/NAD ratio in sub-
jects whose glycogen stores are already depleted by starvation or who have pre-
existing abnormalities in carbohydrate metabolism.   
On the other hand, hyperglycaemia can also be present in patients with AAI . 
Hyperglycaemia has been associated with decreased insulin levels and elevated 
levels of counterregulatory hormones as glucagon, cortisol, growth hormone 
and catecholamines in patients with alcohol-induced ketoacidosis (Umpierrez et 
al., 2000). Indeed, hyperglycemia may also occur in association with alco-
holism, as glucose intolerance may be due, at least in part, to decreased peri-
pheral glucose utilization (Lieber, 1992).  
Hypoglycaemia has been found to be a severe problem in children with AAI 
(Beattie et al., 1986; Lamminpää, 1995; Albers et al., 2004). The clinical signi-
ficance of hypoglycaemia has been highlighted especially in small children, as 
this may rapidly deteriorate their general condition (Bradford, 1984; Lammin-
pää et al., 1990; Yang et al., 1995). Hyperglycaemia can also occur in these 
children or adolescents, probably as a result of the increased cortisol levels due 
to the stimulation of the adrenocorticotropic hormone (van Cauter et al., 1997; 
Plat et al., 1999; Shavit et al., 2012). 
The increased glycaemia from the alcohol abuse seems to be the main cause 
of lactic acidosis in diabetic patients. Krzymien reported that 12 alcohol intox-
icated patients from 29 diabetic patients aged 20–87 were in the Intensive 
Diabetes Care Unit of the Warsaw Medical University in 2007–2012 with the 
diagnosis of lactic acidosis (lactate level >5 mmol/L) (Krzymien et al., 2013). 
There were some cases of severe lactic acidosis after ethanol ingestion  in adults 
without serious illnesses (Lien et al., 1999; Müssig et al., 2008), but usually 
lactate level was in the reference value (Fulop et al., 1986; Auzepy et al., 1985). 
In infants or young children with alcohol intoxication, the lactate level can be 
heighten to a serious level, or >5 mmol/L (Edmunds et al., 2014).   
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2.5.2. Electrolytes 
Hypokalaemia has been considered to be an important factor for patients with 
alcohol withdrawal syndrome or delirium, where hypokalaemia may be a life-
threatening factor (Stasiukyniene, 2002). Hypokalaemia was the most common 
abnormality in the serum electrolytes of AAI children and teenagers (Lammin-
pää et al., 1993). Hyperaldosteronism has been found to be one reason for hypo-
kalaemia, as well as for hypernatraemia in patients with AAI (Hirschl et al., 
2006). Vomiting and diarrhoea in AAI can lead to dehydration that in turn may 
cause disturbances in serum potassium or sodium levels (Perkin et al., 2007).  
There were some studies that reported changing of chloride, calcium, or 
magnesium levels in AAI patients. Fulop et al. described an unexpected and 
unexplained finding of hyperchloraemia in 10 of the 29 (34.5%) patients, with 
serum chloride levels of more than 110 mmol/L (Fulop et al., 1986). Similarly 
to adults, hyperchloraemia has been the most frequent electrolyte disturbance 
(about 33%) in AAI adolescents (Bouthoorn et al., 2011). Rauchenzauner et al. 
reported that in their study the most frequent electrolyte disturbance was hyper-
natraemia (41%), and that only 21% of patients had hyperchloraemia, followed 
by hypermagnesaemia (17%) and hypocalcaemia (15%) (Rauchenzauner et al., 
2005). The depletion of magnesium, phosphate and calcium is frequently found 
in alcohol-dependent patient. These electrolyte disturbances may be associated 
with the alcohol-induced hypoparathyroidism and parathyroid hormone resist-
ance of the skeletal muscle, as well as with the decrease of serum osteocalcin 
(Vamvakas et al., 1998).   
 
 
2.5.3 Hormones 
2.5.3.1. Cortisol 
The level of cortisol, one of the main stress hormones, is increased by various 
stress factors, including pain, inflammation, burns and scares (Carlsson et al., 
2014; Hannibal et al., 2014; McBeth et al., 2005). Some researchers have found 
a positive correlation between heavy drinking and increased serum cortisol con-
centration (Obasi et al., 2015; Husain et al., 2014). Badrick et al. found in their 
study that in 2693 men and 977 women an increased number of alcohol units 
consumed per week and heavy drinking were associated with increased cortisol 
levels (Badrick et al., 2008). Mennella et al. conducted a within-subjects design 
study and reported that alcohol consumption resulted in significantly higher 
cortisol in 17 women when compared with the control condition (Mennella et 
al., 2005). Other researchers have found that neither placebo nor the lower dose 
of alcohol significantly increased cortisol levels, but a relatively high dose of 
alcohol produced a smaller increase of cortisol in heavy drinkers (N=32) com-
pared to light drinkers (N=23) (King et al., 2006).  
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2.5.3.2. Sex hormones 
Many studies have investigated changing serum sex hormone levels in adults 
with AAI, finding that a significant relationship exists between alcohol intake 
and serum sex hormones levels. Serum testosterone concentration has de-
creased, and serum or plasma concentrations of prolactin, cortisol, 17-hydroxy-
progesterone, androstenedione, and dehydroepiandrosterone increased in men 
with AAI compared to their own without ethanol (Välimäki, 1983; Välimäki et 
al., 1984). However, serum estradiol concentration in female patients with AAI 
was not  affected by serum ethanol concentration (Holdstock et al., 2006). In-
creased progesterone levels have been found in 12 alcohol-intoxicated women 
aged 21–35 in the lutheal phase (Holdstock et al., 2006), but ethanol had no 
effect on progesterone levels in men (N=9) or women in the follicular phase; 
whereas Pierucci-Lagha et al. found decreased serum progesterone concentra-
tion in 15 women aged 21–34 in follicular phase (Pierucci-Lagha et al., 2005).  
 
 
2.5.3.3. Other hormones 
Alcohol influences glucose metabolism in several ways in diabetic patients as 
well as in non-diabetic patients. Since alcohol inhibits both gluconeogenesis 
and glycogenolysis, its acute intake without food may provoke hypoglycaemia, 
especially in cases of depleted glycogen stores and in combination with 
sulphonylurea due to increasing insulin level (Pietraszek, et al., 2010; van de 
Wiel, 2004; Magis et al., 2003). Therefore, chronic alcohol consumption is a 
major risk factor for the development of type 2 diabetes (Kim et al., 2015; Kim 
et al., 2010; Baik et al., 2008).  
Frias et al. reported that AAI produces a decrease in growth hormone levels 
in the adolescents of both sexes, without significant alteration of either insulin-
like growth factor-I or insulin-like growth factor binding protein-3, and an 
increase in plasma glucose and a decrease in insulin in the female adolescents 
but not in the males (Frias et al., 2000). The same researchers found that AAI 
also produces a high increase in plasma prolactin (PRL), adrenocorticotropic 
hormone (ACTH) and cortisol in adolescents, and a contradictory behaviour 
with regard to testosterone (T) according to gender: plasma T was increased in 
females and decreased in males. ACTH and PRL correlated positively with 
cortisol, dehydroepiandrosterone-sulphate (DHEAS) and T in females, which 
suggests that ACTH and PRL could synergistically stimulate adrenal androgen 
production; the decrease in T and increase in beta-endorphin in males suggests 
that AAI could have an inhibitory effect on testicular T, perhaps mediated by 
beta-endorphin (Frias et al., 2000). 
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3.  AIMS OF THE STUDY 
1. To study the prevalence of clinical signs in different AAI severity groups 
and the correlation of AILCS with the SAC.  
2. To study the diagnostic performance characteristics (sensitivity, specificity, 
efficiency) of clinical assessment in the diagnosis of AAI in children when 
the “golden standard” in the determination of AAI levels is SAC.  
3. To establish the ratio of SAC to BAC in AAI children. 
4. To study the prevalence of biochemical (glucose, lactate, potassium, and 
sodium) changes in children with AAI, and to establish the impact of SAC 
on the biochemical changes in AAI children. 
5. To describe the hormonal changes (testosterone, estradiol, progesterone and 
cortisol) in children with AAI, and their relationship with biochemical mark-
ers in plasma. 
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4. METHODS AND SUBJECTS 
4.1. Patients 
The study included all 8–18-year-old children hospitalised with acute AAI at 
the two main Estonian children’s hospitals – Tartu University Children’s Clinic 
and Tallinn Children’s Hospital – over a three-year period (Dec 2005–Dec 
2008). No lower age limit was set; that is, all children self-intoxicated by alco-
hol were included. The upper age limit was 18.0 years due to the law, which 
establishes the age limit for patients hospitalized at the children’s hospital in 
Estonia. From the given period, 417 children and adolescents hospitalised with 
suspected AAI were analysed. Twenty children were excluded because their 
SAC was below 0.20 g/L; according to the International Statistical Classifica-
tion of Diseases and Related Health Problems 10th (ICD-10) (http:// 
www.who.int/classifications/icd/en/), they were considered not to have used 
alcohol or all of the blood alcohol had already eliminated by the time of alcohol 
measurement. Narcotic intoxication was confirmed with a rapid urine test in 
three children, who were also excluded. One child, a newborn baby with an 
alcohol concentration of 2.05 g/L, was excluded because she had not consumed 
alcohol by herself. One hundred and fifty- three children in the hormonal study 
and one hundred and sixty-one children in the clinical signs study dropped out 
of the study group due to the following reasons: refused testing, there were 
mistakes in blood drawing, biochemical tests had not been conducted, or the 
medical form had not been completed.  
Due to the legal criteria, where criminal responsibility starts from the age of 
14 years, children were divided into two age groups – 8.0–13.9 years and 14.0–
17.9 years. According to the severity of drunkenness, subjects were divided into 
three groups using two different methods: firstly, according to the clinical signs 
and symptoms estimated by the on-call paediatrician; and secondly, according 
to the SAC as the gold standard in hospitals. The children were divided into 
three groups, based on their serum alcohol concentration:  Group 1 ≥ 0.20–1.49 
g/L, Group 2 1.50–2.49 g/L, and Group 3 ≥ 2.50 g/L.  
The number of subjects increased during the study, so the numbers are 
therefore different. In the biochemistry study from December 2005 to December 
2007, 226 children with suspected AAI were hospitalised at the hospitals (Table 
1). The data of 194 children remained for statistical analysis. Hospitalised child-
ren were aged 10.0–17.9 years, with the mean age being 14.2 years. There were 
94 (48.5%) children in the age group of 10.0–13.9 years and 100 (51.5%) 
children in the age group of 14.0–17.9 years. In total, there were 119 boys form-
ing a male-to-female ratio of 1.6:1.  
In the hormonal study from December 2005 to December 2008, the data of 
264 children was used in the analysis. The sample included 81 children from 
Tartu University Children’s Clinic and 183 from Tallinn Children’s Hospital. 
The mean age of children was 14.2 years (range 8.4–17.9 years). There were 
154 boys, forming a male-to-female ratio of 1.4:1.  
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In the clinical signs study 417 children and adolescents were hospitalised 
with suspected AAI. After excluding children for not meeting the AAI criteria 
and for other purposes (see above), data from the remaining 256 children were 
used in the analysis.  
 
 
Table 1. Number of subjects in different studies. 
Study Hospitalised 
children 
Included as 
AAI children
Totally 
excluded from 
the study 
Remained in 
the study 
(Tartu:Tallinn) 
Ratio of 
boys to 
girls 
Paper I  
(Dec 2005–
Dec 2007) 
 
226 
 
212 
 
32 
 
194 
(78:116) 
 
1.6:1 
Paper II 
(Dec 2005–
Dec 2008) 
 
417 
 
394 
 
153 
 
264 
(81:183) 
 
1.4:1 
Paper III 
(Dec 2005–
Dec 2008) 
 
417 
 
394 
 
164 
 
256 
(76:180) 
 
1.4:1 
 
 
4.2. Reporting of clinical signs of acute alcohol intoxication 
Alcohol intoxication was diagnosed by Diagnostic and Statistical Manual of 
Mental Disorders (DSM IV), and criteria were used for building up a medical 
assessment form (Addendum 1). Upon hospitalisation, the on-call paediatrician 
has to confirm the drunkenness of the child by filling in an anonymous encoded 
medical assessment form. This form included data about the child’s mental sta-
tus (consciousness, balance, speech and behaviour). Consciousness was as-
sessed on a scale from normal to severely aggravated: clear consciousness, dis-
orientation, somnolence, stupor or coma (estimated on the Glasgow Coma 
Scale); balance on a scale of normal, imbalanced or unable to stand (lying); 
speech on a scale of normal, rushed, fast, confused (slurred), or unable to speak, 
and behaviour on a scale of normal, restful, passive, euphoric, aggressive, or 
impossible to assess. Physical status (muscle tone, body temperature, blood 
pressure, pulse, and breathing rate), consumption of alcohol (the time passing 
since the drinking started, the amount of alcohol consumed, and the first or a 
recurrent episode of AAI) and the time of the assessment were reported. Muscle 
tone was assessed on a scale of normal, decreased or increased (with or without 
tremors, spasms, or convulsions). The amount of reported alcohol consumed 
was registered as the number of standard drinks. If the child consumed different 
types of alcohol products or consumed these with other subjects, these para-
meters were taken into consideration in the calculation. According to the clini-
cal signs and the children’s general conditions, the on-call paediatrician was 
asked to subjectively estimate the severity of AAI as mild, moderate, or severe, 
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using instructions introduced to him/her before the study. For example, mild im-
balance, slow speech, or euphoria indicated the mild form; significant im-
balance, slurred speech, disturbed consciousness or memory the moderate form; 
and the inability to stand or severe imbalance, disturbed memory, inability to 
speak or coma the severe form of AAI. 
 
 
4.3. Samples and laboratory tests 
The venous blood samples were drawn about 10–15 minutes after hospitalisa-
tion. The mean time between the ingestion of alcohol and collection of samples 
was 3.25 hours (range: 0.5 to 9 hours).  Three venous blood samples were 
drawn for the measurements of serum and blood alcohol, plasma cortisol and 
sex hormones level, glucose, lactate, sodium, and potassium concentrations. 
Biochemical tests were performed immediately after the collection of samples. 
Lithium heparin plasma was separated and kept at -20oC until hormone meas-
urements were made within a three-month interval at the laboratory of Tartu 
University Hospital. Urine sample was also collected to exclude the use of 
narcotic substances. 
At Tartu University Hospital glucose was determined using the glucose 
oxidase method, lactate with enzymatic colorimetry Cobas Integra 400plus 
(Roche), and potassium and sodium with the ISE direct method AVL 988-4 
(Roche). At Tallinn Children’s Hospital, glucose and lactate were determined 
with enzymatic membranes of amperometric electrodes, and potassium and so-
dium potentiometrically with an ABL 700 Radiometer (Radiometer Analytical). 
Serum ethanol concentration was determined using the enzymatic method 
TDxFLx (Abbott Diagnostics) in both hospitals. Both laboratories participated 
in the Labquality quality control programme. Cortisol, testosterone, estradiol 
and progesterone levels were measured by Immulite 2000 (Siemens Healthcare 
Diagnostics). The hormones laboratory participated in the RIQAS quality con-
trol programme.  
Blood for the measurement of BAC was drawn into sodium fluoride-potas-
sium oxalate vacutainer tubes. The BAC was measured using headspace gas 
chromatography (TurboMatrix 40 Headspace Sampler and Clarus 500) with two 
columns at the Estonian Forensic Science Institute. This laboratory also partici-
pates in the Labquality quality control programme. A urine screening test 
(Multiscreen 10 MTD, Biomedical Diagnostics) for narcotics was used to detect 
amphetamine, methamphetamine, ecstasy, opioids (morphine/heroine), metha-
done, cannabis (Δ-tetrahydocannabinole), cocaine, benzodiazepines, barbitura-
tes and tricyclic antidepressants. 
Reference values of the local laboratories were used to determine the abnor-
malities in biochemical results. Thus, hypokalaemia was defined as plasma po-
tassium level < 3.5 mmol/L, hypoglycaemia as plasma glucose level < 3.3 
mmol/L and hyponatraemia as plasma sodium level < 132 mmol/L. Bio-
chemical results above the upper reference value were defined as hyperkalaemia 
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(potassium level > 5.1 mmol/L), hypernatraemia (sodium level > 145 mmol/L), 
and hyperlactinaemia (lactate level ≥ 2.4 mmol/L). Reference values of estra-
diol, progesterone and testosterone were used for children at the age of puberty. 
Some biochemical results were at clinically critical value. This means that 
with this value the patient may be in imminent danger unless appropriate 
therapy is promptly initiated (Dighe et al., 2006).  
 
 
4.4. Statistical analysis 
Statistical analysis was performed using the Statistica 8.0–10.0 statistical pro-
grammes. Descriptive statistics were used to analyse the children’s character-
istics and exposure data. Spearman Rank Order Correlations (rs) and T-test were 
used to assess bivariate relationships. A p value < 0.05 was considered statistic-
ally significant.  
The diagnostic performance characteristics were performed using the calcu-
lation´s formulas of sensitivity, specificity and efficiency. 
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5. RESULTS  
5.1. Clinical signs in different AAI severity groups and 
comparison of AILCS with the SAC  
5.1.1. The prevalence of clinical signs in different AAI severity groups 
The level of consciousness ranged from normal to coma – somnolence was the 
most common clinical sign (n=92), followed by a normal conscious level 
(n=71) and disorientation (n=51). Coma, estimated as 8 points or less (5 to 8) by 
the Glasgow Coma Scale, was reported in 12 children. Normal balance was re-
ported in 12 children and an imbalanced state in 124 (48.4%); 120 (46.9%) were 
unable to stand. On the speech scale, rushed speech was a frequent sign 
(n=103), followed by confused speech (n=64) and an inability to speak (n=60). 
The most correctly described signs in children in the different SAC groups were 
consciousness (rs=0.16) and speech (rs=0.13). The correlation between estim-
ated drunkenness level and signs was p<0.0001. Passive behaviour was the most 
frequent sign of the AAI children (n=70; 27.3%), followed by restful behaviour 
(n=60) and impossible to assess (n=50).   
 
 
Table 2. The most commonly observed AAI signs for different levels of alcohol 
intoxication  in children.  
                    SAC 
SIGNS 
0.21–1.49 g/L 1.50–2.49 g/L ≥ 2.50 g/L 
Consciousness Mild disorientation, 
somnolence 
Disorientation or 
somnolence 
 
Somnolence to 
coma 
Speech Normal or slow, in 
some cases rushed 
speech 
Slow and confused 
speech 
 
Inability to speak 
or confused speech 
Balance Normal or 
unbalanced 
Unbalanced or not 
possible to assess 
due to condition 
 
Impossible to 
assess due to 
condition 
Behaviour Apathy, restful Apathy, 
aggressiveness or in 
some cases euphoria
 
Not possible to 
assess due to 
condition 
Body temperature 
(oC) 
35.8 (34.2–36.9) 35.6 (33.6–37.2) 35.7 (33.0–37.0) 
Pulse (BPM) 85.4 (48–120) 85.6 (47–140) 83.1 (47–129) 
Systolic blood 
pressure (mmHg) 
112.1 (76–150) 109.1 (76–153) 109.8 (71–140) 
Diastolic blood 
pressure (mmHg) 
66.2 (42–90) 66.5 (30–110) 62.6 (40–90) 
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Muscle tone had decreased in 119 children and increased in eight. Mean 
body temperature, pulse, and blood pressure were not statistically different be-
tween the different alcohol concentration groups. The mean body temperature 
was similar from October to March (mean 35.6±0.65 degrees) and from April to 
September (mean 35.6±0.64). The mean heart rate was 83.9±15.2 beats per 
minute (in the range of 47–132); systolic blood pressure was 108.7±14.3 mm Hg 
(in the range of 71–153) and diastolic blood pressure was 65.3 ±12.1 mm Hg (in 
the range of 35–110). The most commonly observed AAI signs for different 
levels of alcohol intoxication in children are given in Table 2.  
Overall, children had started to consume alcohol 3 hours and 16 minutes 
(ranging from 30 minutes to 9 hours) before the hospitalisation and the main 
type of beverage consumed was strong alcohol, such as spirit cocktails, brandy, 
or vodka (63.2%), followed by light alcohol (21.3%) or both types of beverages. 
The mean amount of alcohol consumed was four standard drinks, ranging from 
0.25 to 16 drinks, and 38.9% of children reported that this AAI was their first. 
The clinical signs did not differ between boys and girls or between the age 
groups.  
 
 
5.1.2. The distribution of subjects by the AILCS and by SAC or BAC 
The distribution of subjects by the levels of AAI estimated by the clinical signs 
(AILCS) and SAC or BAC is given in Table 3.  
 
 
Table 3. Distribution of children (number and %) by alcohol intoxication estimated by 
signs (mild, moderate or severe) and serum or blood alcohol concentrations.  
SAC; 
BAC 
 
AILCS 
Serum alcohol concentration g/L Blood alcohol concentration mg/g 
0.20–
1.50 
mild 
1.51–
2.50 
moderate 
>2.50 
severe 
Total 
 
0.20–
1.50 
mild 
1.51–
2.50 
moderate
>2.50 
severe 
 
Total  
 
Mild 13 
48.2 
12 
44.4 
2 
7.4 
27  
10.5 
20 
74.1 
6 
22.2 
1 
3.7 
27  
10.5 
Moderate 28 
23.9 
77 
65.8 
12 
10.3 
117  
45.7 
52  
44.4 
62 
53.0 
3 
2.6 
117  
45.7 
Severe 8 
10.2 
46 
58.2 
25 
31.6 
79  
30.9 
15 
19.0 
53 
67.1 
11 
13.9 
79  
30.9 
Not 
estimated 
5 
15.2 
24 
72.7 
4 
12.1 
33  
12.9 
7 
21.2 
25 
75.8 
1 
3.0 
33  
12.9 
Total 54 
21.1 
159 
62.1 
43 
16.8 
256 
100 
94 
36.7 
146 
57.0 
16 
6.3 
256 
100 
 
Moderate alcohol intoxication was the most common level assessed by the 
clinical signs (n=117; 45.7%) followed by severe intoxication (n=79; 30.9%). 
The concurrency of the assessed signs  and the SAC occurred in 48.2% (n=13) 
in the mild, 65.8% (n=77) in the moderate and 31.6% (n=25) in the severe 
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alcohol intoxication group. The most noticeable difference was in the severe 
intoxication by the signs group, with a ≥ 0.20–1.50 g/L (or mild) SAC and a 
0.20–1.50 mg/g BAC. The children in this group were seven boys aged 11–14 
years and one 16-year-old girl: their balance was disturbed, muscle tone had 
decreased, they exhibited somnolence and stupor, their memory failed, and 
body temperature was between 34.8–36.2 degrees Celsius. One sixteen-year-old 
girl in this group was mistakenly not assessed for narcotic drugs. Additionally, 
seven boys aged 11–14 years were in the ≥0.20–1.50 g/L SAC group and 
moved to the mild BAC group. In total, 14 younger children were classified as 
being severely alcohol intoxicated by the signs.  
Two children with frequent experience consuming alcohol (16-year-old 
boys) were in a mild state of drunkenness by the signs, but in the severe SAC 
group. One of them was in the moderate alcohol intoxication group by the BAC. 
The main sign of alcohol intoxication they exhibited was disturbed balance 
(Figure 7).  
Age did not correlate significantly with the AAI stage, BAC, or SAC levels, 
except in the younger group of children, where the serum alcohol concentration 
correlated positively with age (rs=0.23; p=0.013).  
5.2. The diagnostic performance characteristics (sensitivity, specificity, effi-
ciency) of clinical assessment in the diagnosis of AAI in children 
Comparing the clinical signs of AAI with the SAC (Table 4), the physicians 
were most accurate in diagnosing the clinical signs in terms of mild intox-
ication, with a sensitivity of 26.5%, specificity of 92%, and efficiency of 77.6%. 
Moderate alcohol intoxication was diagnosed with a sensitivity of 57%, specifi-
city of 54.5%, and efficiency of 56.1%; severe drunkenness with a sensitivity of 
64.1, specificity of 70.6%%, and efficiency of 69.5%. Thus, the average effi-
ciency to diagnose the right AAI severity group, determined by the SAC and 
using a physician´s clinical judgement, was 67.7%. These data also show that 
clinically, doctors estimated the severity of drunkenness to be one level more 
severe than our definition according to the SAC.  
Comparing the clinical signs of AAI with the BAC, mild intoxication was 
diagnosed with a sensitivity of 23.0%, specificity of 94.9%, and efficiency of 
66.8%. Moderate alcohol intoxication was identified with a sensitivity of 
51.2%, specificity of 46.1%, and efficiency of 48.9%; severe intoxication with a 
sensitivity of 73.0%, specificity of 67.3%, and efficiency of 67.7%. Thus, the 
average efficiency in diagnosing the right AAI severity group, determined by 
the BAC and using the physician´s clinical judgement, was 61.1%.  
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Table 4. The sensitivity, specificity and efficiency of clinical assessment in the 
diagnosis of AAI comparing with the SAC or BAC.  
AILCS 
 
Diagnostic 
performance % 
Mild 
vs 
SAC 
Moderate
vs 
SAC 
Severe 
vs 
SAC 
Mild 
vs 
BAC 
Moderate 
vs 
BAC 
Severe 
vs 
BAC 
Sensitivity 26.5 57.0 64.1 23.0 51.2 73.0 
Specificity 92.0 54.5 70.6 94.9 46.1 67.3 
Efficiency 77.6 56.1 69.5 66.8 48.9 67.7 
 
 
5.3. The establishment of SAC/BAC ratio in children 
There was the shift from a higher SAC to lower BAC in all AAI groups, and the 
correlation between the serum and blood alcohol concentrations was very good 
(rs=0.93; p<0.0001) (Figure 2). 
 
 
Box Plot of multiple variables grouped by  clinical decision
Median; Box: 25%-75%; Whisker: Min-Max
 BAC
 SAC
1 2 3 9
clinical decision
0,0
0,5
1,0
1,5
2,0
2,5
3,0
3,5
4,0
4,5
 
Figure 2. The correlation between blood alcohol concentration (BAC) and serum 
alcohol concentration (SAC) in alcohol-intoxicated children. X-axis: Alcohol intox-
ication levels by clinical decision or signs (1: mild; 2: moderate; 3: severe; 9: not 
estimated). Y-axis: BAC (mg/g) compared with SAC (g/L).  
 
 
The mean ratio SAC:BAC was 1.19:1±0.13, from 1.17:1 in the mild AAI group 
to 1.19:1 in the moderate and severe AAI groups. The mean ratio was not signi-
ficantly different between boys and girls or between the different age groups. 
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5.4. The prevalence of biochemical  
(glucose, lactate, potassium and sodium) changes  
in serum in children with AAI, and the impact of  
SAC on the biochemical changes in serum 
The summary of ethanol, biochemical and hormonal markers concentrations in 
different AAI groups is given in Table 5.  
 
 
Table 5. Ethanol, glucose, lactate, sodium and cortisol concentrations in all; estradiol 
and progesterone levels in girls, testosterone level in boys in alcohol-intoxicated 
children. 
Analyte Mean ± SD 
range 
AAI Gr 1 
0.21–1.49 
g/L 
AAI Gr 2 
1.50–2.49 
g/L 
AAI Gr 3 
≥2.50 g/L 
Reference 
value 
Ethanol 
(g/L) in 
serum 
2.01 ± 0.60 
0.47–4.08 
1.24 ± 0.24 
0.47–1.49 
1.99 ± 0.27 
1.50–2.48 
2.89 ± 0.31 
2.52–4.08 
<0.20 
Glucose 
(mmol/L) 
6.1 ±1.2 
3.0–13.1 
6.0±1.4 
3.5–12.7 
6.1±1.2 
3.0–13.1 
5.9±0.9 
4.3–8.3 
3.3–-6.1 
Lactate 
(mmol/L) 
2.8 ± 0.9 
0.5–6.6 
2.8±1.0 
0.5–5.6 
2.8±0.9 
1.1–6.6 
2.5±0.8 
1.0–5.2 
<2.4 
Sodium 
(mmol/L) 
142.7 ± 3.1 
132.0–154.5 
142.1±2.9 
133.0–148.0
142.6±3.1 
132.0–151.0
143.9±3.2 
138.0–154.5
132–145 
Potassium 
(mmol/L) 
3.6 ± 0.5 
2.1–6.9 
3.6±0.7 
2.1–6.9 
3.5±0.4 
2.4–5.3 
3.6±0.4 
2.8–5.0 
3.5–5.1 
Estradiol 
(pmol/L) 
210.1±185.1 
<73.0–910.0 
184.3±144.5
<73.0–525.0
209.0±186.3
<73.0–910.0
240.9±218.0
<73.0–903.0
101.0–
1468.0 
Progesterone 
(nmol/L) 
4.87±5.2 
<0.64–32.4 
3.3±1.9 
0.6–7.3 
5.2±5.7 
0.6–32.4 
4.8±4.5 
0.6–22.1 
1.5–67.0 
Testosterone 
(nmol/L) 
8.5±6.2 
<0.7–25.7 
6.2±5.7 
<0.7–19.4 
8.7±6.3 
<0.7–23.0 
11.3±5.8 
0.74–25.7 
9.9-52.4 
Cortisol 
(nmol/L) 
624.9±242.2 
87.5–1294.0 
614.2±232 
89.4–1013.0
656.6±232.8
139.0–
1294.0 
520.2±263.0
87.5–1159.0
140.0–
600.0 
(mornings) 
 
½ from 
morning 
level 
(evenings) 
 
Girls in younger age group (n=3) in the first group of alcohol concentration, 
SAC ≥ 0.20–1.49 g/L, had significantly higher serum alcohol concentration than 
boys (n=15; 1.40 vs. 1.21 g/L, p=0.02), whereas opposite tendency was seen in 
older age group (1.17 vs. 1.26 g/L), however, the latter difference was not stat-
istically significant.  
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5.4.1. Glucose 
In the overall group, there was a statistically significant, but relatively weak, 
negative correlation between the glucose concentration and age (r=-0.21; 
p=0.003), i.e. glucose levels decreased with increasing age (Figure 3).  
 
 
 
 r = -0.2155; p = 0.0025; r2 = 0.0465 
Figure 3. The relationship between plasma glucose concentration (mmol/l) and age 
(years) (r=-0.21; p=0.003) in acutely alcohol-intoxicated children. 
 
 
This correlation remained significant after correcting for blood alcohol concen-
tration. In the older age group plasma glucose levels tended to be within re-
ference range, whereas in the younger age group there was a tendency towards 
increased glucose levels. 
As seen in the scatter plot, a glucose level above the reference value (6.1 
mmol/L) was evident in 78 (40.2%) of the children. In 29 (15%) children, the 
glucose level was equal to or higher than 7 mmol/L. In older children glucose 
values were more stable within reference values, except for four very high 
values of more than 9 mmol/L that would have necessitated further studies in 
respect to glucose metabolism. None of our subjects were hypoglycaemic, i.e. 
had plasma glucose < 3.3 mmol/L.  
 
 
10 11 12 13 14 15 16 17 18 19
decimal age
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5.4.2. Lactate 
Hyperlactinaemia (>2.4 mmol/l) occurred in 66% of the children and there were 
three children with lactate levels above 5 mmol/L. There was a statistically sig-
nificant, but relatively weak negative correlation (r=-0.31; p=0.0001) between 
lactate concentration and age, i.e. lactate values of older children were more 
within the reference range, whereas increased lactate values were more common 
in younger children. This correlation remained significant after correcting for 
blood alcohol concentration.  
 
 
5.4.3. Potassium 
The mean serum potassium concentration (3.6 mmol/L) was very close to the 
lower reference limit of 3.5 mmol/L, and half of the children (50%) were hypo-
kalaemic (< 3.5 mmol/L). There was a statistically significant but relatively 
weak positive correlation between plasma potassium concentration and age 
(r=0.3; p < 0.0001), i.e. the younger children had more hypokalaemia (64%) 
than older children (Figure 4). This correlation remained significant after cor-
recting for blood alcohol concentration.  
Five children (2.6%) had hypokalaemia in the critical value, e.g. under 2.8 
mmol/L.  
 
 
 
r = 0.2920; p = 0.00004; r2 = 0.0853 
Figure 4. The relationship between plasma potassium concentration (mmol/l) and age 
(years) (r=0.29; p=0.0004) in acutely alcohol-intoxicated children. 
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5.4.4. Sodium 
In general, plasma sodium concentration was within reference range, although 
in five children it had relatively high values (above 150.0 mmol/L).  
 
 
5.4.5. The impact of SAC on the biochemical changes 
The plasma glucose concentrations were slightly lower for the girls in each 
alcohol concentration group compared to boys, but the differences were not 
statistically significant.  
The mean plasma lactate concentration was above the reference value (< 2.4 
mmol/L) in each alcohol concentration group, except for the girls in ≥ 0.20–
1.49 g/L group.  
Plasma potassium concentration did not differ between the different alcohol 
concentration groups, but in the younger age children group there was a stat-
istically significant but relatively weak negative correlation between the ethanol 
concentration and plasma potassium concentration values (r=-0.23; p=0.028). 
The mean plasma sodium concentration tended to be slightly higher in the ≥ 
2.50 g/L alcohol concentration group. The plasma sodium concentration correlation 
to alcohol concentration was statistically significant, but a relatively weak positive 
correlation (r=0.21; p=0.023) (Figure 5). There was a strong correlation (p=0.006) 
between the alcohol levels above 1.50 g/L and sodium concentrations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Correlation of sodium (mmol/l) and alcohol (g/L) concentrations. 1: 0.20–
1.49 g/L, 2: 1.50–2.49 g/L, 3: ≥2.50 g/L ethanol concentration in serum. 
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5.5. The hormonal changes (testosterone, estradiol, 
progesterone and cortisol) in AAI children and their 
relationship with plasma biochemical markers 
 
In girls, plasma estradiol and progesterone concentration did not significantly 
correlate to age, but for boys there was a positive correlation between plasma 
testosterone concentration and age (r=0.63; p<0.0001). Plasma cortisol concen-
tration in the whole group correlated positively with plasma glucose levels 
(r=0.29; p<0.05) (Figure 6).  
 
 
 
Figure 6. Correlation between plasma cortisol (nmol/l) and glucose (mmol/l) levels 
(r=0.29; p<0.05). 
 
 
Cortisol concentration correlated positively with plasma lactate concentration 
(r=0.32; p<0.0001) and negatively with sodium level (r=-0.25; p<0.0001) 
(Figure 7).  
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Figure 7. Correlation between plasma cortisol (nmol/l) and sodium (mmol/l) levels  
(r=-0.25; p<0.0001). 
 
 
Plasma progesterone concentration was positively correlated with cortisol (r=0.62; 
p<0.05), glucose (r=0.30; p<0.05), and lactate (r=0.22; p<0.05), and negatively 
with sodium levels (r=-0.22; p<0.05).  
Plasma testosterone concentration was positively correlated with plasma po-
tassium (r=0.29; p<0.05) and sodium (r=0.23; p<0.05), and negatively with lact-
ate levels (r=-0.17; p<0.05). 
For the group of children with serum alcohol concentration ≥0.20–1.49 g/L, 
testosterone concentration for boys correlated positively with age (r=0.80; 
p<0.0001) and with sodium concentration (r=0.34; p<0.05). In girls, progester-
one concentration correlated positively with glucose (r=0.62; p<0.05) and corti-
sol (r=0.67; p<0.01) levels.  
Among those with a serum alcohol concentration of 1.50–2.49 g/L, testoster-
one concentration for boys correlated positively with age (<0.0001; r=0.53) and 
with potassium level (p<0.002; r=0.32). In girls, the progesterone level correla-
ted positively with age (p<0.05; r=0.23) and cortisol (p<0.0001; r=0.65) con-
centration and negatively with sodium (p<0.05; r=-0.24) level.   
Among the group of children with serum alcohol concentration more than 
2.50 g/L, testosterone concentration in boys correlated positively with age 
(p<0.03; r=0.43) and negatively with glucose (p<0.01; r=-0.48) level. Lactate 
level only correlated positively with estradiol (p<0.02; r=0.62) level in girls 
with a serum alcohol concentration of more than 2.50 g/L.   
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6. DISCUSSION  
The consumption of alcohol among children is a growing problem in many 
countries, including Estonia, and therefore our study involved a large number of 
children: overall, 212 intoxicated minors admitted to 2 hospitals over 2 years, 
and 394 over 3 years. The ratio of girls and boys, from 1:1.4 to 1:1.6, was sim-
ilar to other studies (Marchi et al., 2003; McIntosh et al., 2004), where gener-
ally more boys were involved. The mean age of the children in our study (14.2 
years) was similar to that in other studies (Schöberl et al., 2008; Weinberg et 
al., 2006), except we encountered significantly fewer 16-year-old adolescents. 
In our study were three children younger than 10 years (8.4–9.9 year-old; one 
boy and two girls). We did not ask questions about their families in the medical 
assessment form, but paediatricians noted, that all these children were from 
families with social problems. Some studies showed the different pattern of 
gender and age in AAI children, where the ratio of boys and girls was quite 
equal and the mean age was over 15 years (Bouthoorn et al., 2011; Kaminska et 
al., 2012; Kuzelova et al., 2009; van Hoof et al., 2010). We did not compare 
our results with other reports on effects of acute intoxication in young adults. 
Most of these studies have been done in a controlled situation with volunteers, 
with mean alcohol concentration in the blood up to 0.80–1.00 g/L (Cameli et 
al., 2009; Davies et al., 1999). The mean measured blood serum concentration 
of alcohol in our study subjects was 2.01 g/L, and we therefore did not consider 
these two situations comparable. Most frequently, children in our study were 
hospitalised with alcohol concentration between 1.50–2.50 g/L (N=232). Other 
studies have found similar results (Schöberl, 2008; Weinberg, 2006). Five chil-
dren were in potentially lethal SAC or > 3.5 g/L (3.59–4.08 g/L): three of them 
were boys (one 14 and two 17-years-old) and two girls were 15 years old.  The 
youngest child was in a coma and had a critically low potassium level (2.9 
mmol/l). One girl had critically high lactate concentration (> 5.2 mmol/l), but 
the paediatrician assessed her clinical condition as moderate drunkenness. How-
ever, it is quite likely that the majority of children with mild AAI do not go to 
the hospital because their general condition is not so greatly affected. There 
were 23 children with previous health problems: the most often were psychiatric 
and asthmatic diseases (five cases of both), three children were epileptic, two 
with previous serious trauma, allergic problems, or heart diseases (insufficiency 
of the mitral valve and ventricular septal defect). The single children had hypo-
thyroidism, diabetes (glucose concentration was 12.7 mmol/L), myxoma, dia-
betes and epilepsy together (glucose level was 9 mmol/L).  
 
 
6.1. Clinical signs in different AAI severity groups and 
comparison of AILCS with the SAC  
There have been very few studies about clinical symptoms of acute alcohol 
intoxication in children; most of these have been in children with a relatively 
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high level of alcohol concentrations (Madsen, 1990; Lamminpää, 1995). Clin-
ical symptoms of AAI in children have been found similar to those seen in 
adults, but combining clinical signs and blood alcohol measurements in children 
will significantly help to asses child’s general status. CNS disturbance signs 
were correlated with the SAC in the children, but the correlation was stronger 
with the BAC. The disturbed consciousness and balance problems in the chil-
dren were similar to those seen in adults with AAI, as alcohol induces the 
inhibition of CNS and the disturbance of coordination, memory, consciousness, 
and speech. Reduced consciousness was also the most common clinical finding 
by other studies (Bouthoorn et al., 2011; Weinberg et al., 2006), but the second 
important sign was hypothermia (Madsen, 1990). Ethanol itself enhances the 
decline in body temperature by the dilatation of the peripheral blood vessels, 
and therefore body temperature can slightly decrease. However, in our study we 
did not find statistically significant differences in body temperatures between 
seasons. Seasonal differences in body temperature can occur in areas with large 
temperature differences, as in Estonia, but the children in our study were mostly 
hospitalised from interior rooms. The few who were found outside were dis-
covered and studied in the summer. In our study, slurred speech was not a 
useful sign in determining the severity of AAI in children, because it was com-
mon at every level of AAI. Although slurred speech is not common in chron-
ically intoxicated adults even with a high BAC (Pisoni et al., 1989; Sobell et al., 
1982), it is common in children with AAI. Change in muscle tone was unpre-
dictable in some children, as alcohol usually produces a decrease in muscle 
tone, but there were eight children with increased muscle tone, possibly due to 
aggressiveness.  
 
 
6.2. The diagnostic performance characteristics of clinical 
assessment in the diagnosis of AAI in children 
Estimation of the clinical signs and BAC of AAI together in the everyday work 
of hospitals is especially important for the early detection and intervention in 
the hazardous drinking habit of young people (Touquet et al., 2012). One of our 
major limitations was that we did not use a standardized method to determine 
the level of AAI by clinical signs and did not perform inter-rater reliability 
testing. However, all on-call doctors in this study have graduated from the only 
medical faculty in Estonia and their medical training in paediatrics has been 
similar. Therefore, we presume that there can be no major differences in the 
evaluation of a child admitted to the hospital, and the severity of AAI should be 
comparable. In comparing BAC and estimated AAI levels by the clinical signs, 
we found that doctors often clinically estimated the severity of intoxication in 
children as one or even two stages more severe than that indicated by the SAC. 
Thus, in comparing the diagnostic characteristics of clinical judgement between 
AAI groups determined biochemically, it is clear that the clinical judgement 
matched better with AAI determined by the SAC rather than by the BAC.   
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There were also 15 children for whom BAC was in the mild group (0.20–
1.50 mg/g) but who were clinically assessed as severe AAI by the paediatrician 
i.e. the doctor estimated the severity of AAI as two stages more severe than that 
determined biochemically. Most of these children were younger than 14 years 
and the leading sign was strongly disturbed balance. The younger children prob-
ably had not used alcohol before and were therefore probably very sensitive to 
alcohol, or due to the children’s organ systems being immature. The body of a 
younger child contains more water than in older children and adults, and as 
alcohol disperses easily in water of the body, the SAC in children may even be 
relatively low, but there are remarkable clinical signs of AAI due to the direct 
effect of alcohol on CNS. Acute alcohol intoxication signs in younger children 
can change quickly due to the differences in the alcohol metabolism rate, which 
in children is twice higher rate than that found in adults (Donovan, 2009; 
Leung, 1986). 
In our study all the children were Caucasians, but generally the ethnicity of 
the subjects should be taken into consideration, as low activity of aldehyde 
dehydrogenase enzyme has been found in some Asians (Crabb et al., 1989; 
Thomasson et al., 1991).  
 
 
6.3. The establishment of SAC/BAC ratio in children 
Many authors have studied the ratio between the SAC and BAC in adults 
(Barnhill et al., 2007; Labianca, 2002; Rainey, 1993). The results of these stud-
ies can be used in legal cases, especially in those related to traffic incidents. 
Ethanol is spread well in the water of the body, and its concentration in serum is 
higher than in blood because the water content of the serum is higher than in the 
whole blood. The ratio between the SAC and BAC in adults has been found 
from 1.04:1 to 1.26, with an average of 1.14–1.15:1 (Charlebois et al., 1996; 
Rainey, 1993). We found that the average SAC:BAC ratio in children was a bit 
higher (1.19:1) than that seen in adults, probably from the lower haematocrit of 
the blood, with no difference between age groups or gender of the children.  
 
 
6.4. The prevalence of biochemical changes in children 
with AAI, and the impact of SAC on the biochemical 
changes in plasma 
Alcohol consumption causes many changes in plasma glucose, lactate, po-
tassium, and sodium concentrations, and is a complex process. For normal 
ranges, we have used local laboratory reference values that are based on recom-
mended international references (Burtis et al., 2006; Heil et al., 2004).  
Many studies have found that hypoglycaemia is a common problem in AAI 
(Hart et al., 1998; Kerr et al., 1990; Wilson et al., 1981). A large proportion of 
scientific articles support the idea that the reason for hypoglycaemia resulting in 
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AAI is the inhibition of gluconeogenesis and glucogenolysis by alcohol 
(Marshall et al., 2008; Siler et al., 1998). However, other opposing articles also 
exist (Mokuda et al., 2004). In our study, we have also seen more of a tendency 
towards higher glucose levels than hypoglycaemia. Alcohol may increase glu-
cose levels through inhibiting the basal insulin secretion although glucose-stim-
ulated insulin secretion has been found not to be impaired, from increasing 
cortisol secretion and enhancing gluconeogenesis from lactate (Shin et al., 
2002). Increased cortisol level in a stressful situation is one of the most im-
portant factors in the mechanism of increasing glucose level.  
Hyperlactinaemia was a common finding in our children, which was a fea-
ture similar to the other studies (McDonald et al., 1994; Umpierrez et al., 2000). 
One cause for the lactic acidosis is tissue hypoxia due to mild hypothermia or 
ethanol-induced central nervous system depression and altered blood vessel 
tone (Lien et al., 1999). Serum lactate concentration above 5 mmol/L is con-
sidered to be dangerous, because such lactate level has been associated with in-
creased 3- and 30-day mortality levels in intensive care patients with acute alco-
hol intoxication (Stacpoole et al., 1994). In our study, there were three children 
with lactate levels above 5 mmol/L. Thus, serum lactate level should be meas-
ured in every child with AAI. The other possible reason for lactic acidosis is en-
hanced anaerobic glucose metabolism, which leads to increased lactate pro-
duction.  
According to the plasma potassium reference values (3.5–5.1 mmol/L), there 
was a tendency towards hypokalaemia. The mean plasma potassium level was 
near the lower reference value – 3.6 mmol/L, the lower quartile being 3.3 mmol/L 
and the upper quartile 3.9 mmol/L. Critically low potassium values, i.e. < 2.8 
mmol/L, were present in 2.6% of children (n=5) in the biochemistry study. In 
the hormonal study, a critically low potassium level was found in 3.4% of chil-
dren (n=9) and required correction with a potassium infusion. Continuous 
monitoring of these hypokalaemic patients was also necessary, as they were dis-
orientated, somnolent, and their mean body temperature tended to be lower 
(35.4oC) than in other children with normal potassium levels (mean temperature 
35.8oC). No arrhythmias were reported in any children. 
This might result from ethanol-induced lactic acidosis and development of 
high glucose level, since these two factors may decrease the cellular level of po-
tassium and its increased loss with urine and vomiting.  
There was also a tendency towards hypernatraemia. However, in most cases 
it was mild and the plasma sodium levels exceeded 150 mmol/L only in five 
children. The most likely cause for hypernatraemia is not the excess of primary 
sodium, but the water deficit and hyperaldosteronism, which commonly occur 
in AAI.  
 
Potassium and sodium were positively correlated with age in all groups of 
drunken children and correlated negatively with glucose and lactate. The pos-
sible reason for the differences in the correlations is that younger children were 
more affected by alcohol than older children were. 
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Despite the good statistical significance of our findings, the correlation 
coefficients were relatively low (r=-0.3 lactate concentration and age; r=0.3 po-
tassium concentration and age; r=-0.21 glucose concentration and age; r=-0.23 
ethanol and potassium concentrations; r=0.21 ethanol and sodium concent-
rations).  
 
 
6.5. The hormonal changes in AAI children and their 
relationship with plasma biochemical markers  
Alcoholism and heavy drinking has been associated with a dysregulation of the 
hypothalamic-pituitary-adrenal axis, with alcoholics showing higher basal 
cortisol levels and reduced inhibitory feedback control (Gianoulakis et al., 
2003; Thayer et al., 2006). Acute alcohol intoxication has also been shown to 
stimulate the hypothalamic pituitary adrenal axis and to increase plasma cortisol 
concentration (Owens et al., 1992; Patchev et al., 1995; Frias et al., 2002). For 
most of the children hospitalised at evening or night (from 5 p.m. to 2.30 a.m.; 
N=191), when cortisol secretion is normally very low, about half of the amount 
was secreted in the morning. The majority of patients had plasma cortisol levels 
above 110–460 nmol/l, the maximum reference value for that time of day (4–7 
p.m. 80–460 nmol/L; midnight 30–110 nmol/L) (Marks et al., 2002). Pierucci-
Lagha et al. found no change in cortisol levels in adult volunteers with an alco-
hol concentration of about 1.00 g/L. Other studies have found increasing 
cortisol levels in humans acutely intoxicated with ethanol (Välimäki et al., 
1984; Wirth et al., 2007). In our study, cortisol concentration was increased in 
all alcohol concentration groups. The most likely cause for rising cortisol levels 
is the stressful situation of the organism from the central nervous system being 
depressed by alcohol intoxication. 
The study showed a positive correlation between progesterone and cortisol. 
Most progesterone in males is created during testicular production of testoster-
one, and most in females by the ovaries; it is also produced in the brain and by 
the adrenal gland, however, where progesterone is an indirect precursor to 
cortisol (Baulieu et al., 2001). Like cortisol, progesterone is released in re-
sponse to the ACTH (Wirth et al, 2007; Genazzani et al., 1998).  
Estradiol level was not correlated with alcohol concentration in our study, 
which was similar to the other studies (Sarkola et al., 1999). In our study a lot 
of girls were at the pre-menarche age or without a regular menstrual cycle. Girls 
older than 13–14 years were often in medically serious health conditions and we 
didn't obtain information about their menstrual cycle. 
Cortisol elevates the level of plasma glucose (Verberne et al., 2014; Garrel 
et al., 1995), and some studies have shown that the elevation of glucose is more 
pronounced in the evening than in the morning (Plat et al., 1999). Similar 
cortisol and glucose results were notable in our study.   
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7. CONCLUSIONS  
1. The severity of alteration of consciousness was the leading sign in the clinical 
evaluation of children with AAI, and correlated well to the SAC. Disturbances 
in speech and balance were also common in AAI.   
 
2. The variation of AAI signs could be confirmed by measuring the SAC as the 
“AAI gold standard” in hospitals. The average efficiency in diagnosing the right 
AAI severity group, determined by the SAC, was 67.7% in AAI children. 
Clinically, doctors tended to estimate the severity of drunkenness to be one 
level more severe than that determined by SAC.   
 
3. The SAC/BAC ratio of 1.19 was established, and should be used in children 
regardless of their gender or age.   
 
4. Glucose levels above the reference value, hyperlactinaemia, and hypo-
kalaemia were common biochemical findings in children hospitalized with AAI. 
Hypoglycaemia, at least in our study, was rare. Plasma glucose, lactate, po-
tassium, and sodium levels should be measured in all children hospitalized with 
AAI. Biochemical changes occurred in all SAC levels, but particularly were in 
SAC above 1.50 g/L.  
 
5. Increased plasma cortisol level above reference values was a common finding 
in children with AAI. Cortisol correlated positively with plasma glucose level, 
and in girls, with plasma progesterone concentration. 
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9. SUMMARY IN ESTONIAN 
Etüülalkoholi intoksikatsiooni kliiniline pilt ja  
olulisemad biokeemilised muutused lastel 
Sissejuhatus 
Etanool on kõige enam kuritarvitatud aine nii Ameerika Ühendriikides, kui ka 
Lääneriikides, kaasa arvatud Eestis. Rohke alkoholi tarvitamisega kaasnevad 
kasvava tendentsiga alkoholist tingitud probleemid ka lastel ja noorukitel (Madu 
et al., 2003; Meyer et al., 2003; Meyer et al., 2008; Schöberl et al., 2008; 
Sutherland et al., 1998; Woolfenden et al., 2002). Laste hälbiva käitumise 
uuring-2 näitas, et keskmiselt 53% Eesti 15–16 aastastest lastest oli tarvitanud 
rohkelt alkoholi vähemalt korra viimase 30 päeva jooksul. Umbes 86% 13–16 
aastastest noorukitest Eestis oli tarvitanud alkoholi vähemalt korra elus ning esi-
mene alkoholi tarbimine toimus tüdrukutel 11.3 ja poistel 10.7 a vanuselt 
(Markina et al., 2007). Vähemalt 15 aastaste inimeste poolt tarbiti kogu maa-
ilmas 2005. aastal  keskmiselt  6.13 liitrit puhast etanooli (WHO, 2011).  Eestis 
on alkoholi tarvitamine vähenemistendentsiga: 2005. a tarvitati 22.0 liitrit pu-
hast etanooli inimese kohta (WHO, 2011) ning 2013. a oli kogus vähenenud 
11.9 liitrini (Estonian Institute of Economic Research, 2014).  
Somnolentsus, stuupor, düsorientatsioon ja tasakaaluhäired on hästituntud  
alkoholi intoksikatsioonile vihjavad kesknärvisüsteemi (KNS) sümptoomid. 
Uuringud, mis kirjeldavad head korrelatsiooni KNS sümptoomide ja vere alko-
holi kontsentratsiooni vahel, on teostatud täiskasvanutel (McKnight et al., 1997; 
Zoethout et al., 2011), kuid lastel ei ole teadaolevalt läbi viidud. Bouthoorn 
kaasautoritega (Bouthoorn et al., 2011) leidis retrospektiivses uuringus, et tead-
vushäired (45%) ja hüpotermia (43.1%) olid sagedasemad hospitaliseeritud 
alkoholijoobes laste kliinilised tunnused. 
Juriidilistel juhtudel on vajadus kalkuleerida seerumi ja vere alkoholi kont-
sentratsiooni suhe, mis täiskasvanutel on 1.12:1–1.18:1 (Barnhill et al., 2007), 
kuid laste kohta andmed puuduvad.  
Alkoholijoobes lastel on kliinilist leidu kirjeldatud väga üldiselt ning pole 
seostatud alkoholi kontsentratsiooniga seerumis või veres. 
Alkoholist tingitud biokeemilisi muutusi, nagu laktatsidoosi, hüpernatree-
miat, hüpokaleemiat, hüpoglükeemiat või hüperglükeemiat on kirjeldatud alko-
holijoobes täiskasvanutel. Lastel on biokeemilistest muutustest probleemsei-
maks peetud hüpoglükeemiat ja hüpokaleemiat, kuid kirjeldused on peamiselt 
juhtumipõhiselt ning tavaliselt on uuritavad lapsed olnud raskes alkoholijoobes. 
Hüperglükeemiat on seostatud kortisooli taseme tõusuga ning laktatsidoosi 
tekkega.  
Seerumi alkoholi kontsentratsiooni mõju suguhormoonidele on mitmetine: 
on leitud, et östradiooli tase alkoholi toimest ei muutu, samas progesterooni 
taseme muutust on käsitletud erinevalt. Holdstock (Holdstock et al., 2006) lei-
dis, et follikulaarses faasis progesterooni tase alkoholi toimel ei muutu, kuid  
Pierucci-Lagha kaasautoritega (Pierucci-Lagha et al., 2005) kirjeldas 
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progesterooni kontsentratsiooni vähenemist. Testosterooni tase väheneb alko-
holi tarvitamisel, kuid enam väljendub alkoholi efekt kroonilisel tarvitamisel. 
 
 
Uuringu eesmärgid 
Uurida kliinilisi tunnuseid ägeda alkoholi intoksikatsiooni erinevatel raskus-
astmetel ning ägeda alkoholi intoksikatsiooni raskusastmete korrelatsiooni see-
rumi alkoholi kontsentratsiooniga; 
leida lastel esineva ägeda alkoholi intoksikatsiooni kliinilise hindamise diag-
nostilise kasutuse  tõhusus kui kasutada ägeda alkoholi intoksikatsiooni raskuse 
hindamisel „kuldse standardina“ seerumi alkoholi kontsentratsiooni; 
tuvastada seerumi alkoholi kontsentratsiooni ja vere alkoholi kontsentrat-
siooni suhe ägeda alkoholi intoksikatsiooniga lastel; 
teha kindlaks ägeda alkoholi intoksikatsiooniga laste biokeemiliste analüü-
tide (glükoos, laktaat, kaalium, naatrium) muutuste esinemine ning tuvastada 
seerumi alkoholi kontsentratsiooni mõju biokeemilistele muutustele; 
kirjeldada ägeda alkoholi intoksikatsiooniga laste hormonaalset (testos-
teroon, östradiool, progesteroon, kortisool) staatust ning hormoonide suhet plas-
ma biokeemiliste analüütidega. 
 
 
Meetodid ja patsiendid 
Uuringus osalesid Tartu Ülikooli Lastekliinikusse või Tallinna Lastehaiglasse 
ägeda alkoholi intoksikatsiooniga hospitaliseeritud 8–18 aastased lapsed aja-
vahemikus detsember 2005 kuni detsember 2008. Uuringu 3 aasta jooksul kogu-
nes teave 417 lapse ja nooruki kohta, kellel kahtlustati ägedat alkoholi intoksi-
katsiooni. Neist välistati kohe 20, kuna alkoholi kontsentratsioon seerumis oli 
väiksem kui 0.2 g/L, kolm last, kellel tuvastati narkootilise aine intoksikatsioon, 
1 vastsündinud laps, kuna ei olnud ise endale alkoholi manustanud. Erinevatel 
põhjustel (uuringus osalemisest keeldumine, verevõtu vead, laboriuuringuid ei 
thetud või kliinilise läbivaatuse protokolli ei täidetud) välistati 153 last hor-
moonide- ning 161 last kliiniliste tunnuste uuringust.  Lapsed jaotati vanuse 
järgi kahte gruppi: 8.0–13.9 aastat ning 14.0–17.9 aastat. Joobe raskuse järgi 
jaotati lapsed kolme gruppi kasutades kahte erinevat põhimõtet: kliiniliste tun-
nuste alusel (kerge, mõõdukas, raske) ja SAC aluseks võttes (1. grupp ≥0.20–
1.49 g/L, 2. grupp 1.50–2.49 g/L, 3. grupp ≥2.50 g/L).  
Laste arv suurenes uuringu käigus, mistõttu esimeses uuringuetapis detsem-
ber 2005 kuni detsember 2007, biokeemiliste muutuste uuringus, osales 226 
hospitaliseeritud alkoholijoobe kahtlusega lapsest 194, vanuses 10.0–17.9 
(keskmine 14.2) aastat, poiste:tüdrukute suhtega 1.6:1 (Tabel 1). 
Teises etapis detsember 2005 kuni detsember 2008, hormonaalsete muutuste 
uuringus, jäi uuringusse 264 last vanuses 8.4–17.9 (keskmine 14.2) aastat 
poiste:tüdrukute suhtega 1.4:1 ning kolmandas etapis samast ajavahemikust oli 
uuringus 256 last. 
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Kliiniliste tunnuste fikseerimiseks kasutati anonüümset kodeeritud protokolli 
(Lisa 1), mis sisaldas andmeid lapse kesknärvisüsteemi seisundi (teadvus, tasa-
kaal, kõne, käitumine) kohta astmelise skaalana. Samuti fikseeriti andmed füü-
silise seisundi (lihastoonus, kehatemperatuur, vererõhk, pulss, hingamissage-
dus) ja manustatud alkoholi kohta. Pediaatritelt küsiti lapse kliinilise seisundi 
alusel hinnangut joobe raskusastme (kerge, mõõdukas, raske) kohta. 
Vereproovid koguti 10–15 minutit peale hospitaliseerimist seerumist ja 
verest alkoholi kontsentratsiooni määramiseks ning plasmast glükoosi, laktaadi, 
naatriumi, kaaliumi, kortisooli ja suguhormoonide määramiseks. Biokeemilised 
analüüsid ja alkoholi kontsentratsiooni määramine teostati kohe peale proovide 
kogumist, hormoonide määramiseks Li-hepariini plasma külmutati –20oC juures 
määramiseni Tartu Ülikooli Kliinikumis. Uriiniproov võeti narkootiliste ainete 
kasutamise välistamiseks. Vere etanooli kontsentratsioon määrati Eesti Kohtu-
ekspertiisi Instituudis. Analüütide tulemuste muutusi hinnati labori referents-
väärtuste alusel.  
 
 
Tulemused 
Alkoholi intoksikatsiooni kliinilistest tunnustest erinevates intoksikatsiooni ras-
kusgruppides esines sageli  teadvusehäire: somnolentsus (N=92), düsorientat-
sioon (N=51) ja kooma 12 lapsel (GKS 5–8 punkti). Sagedaseim AAI kliiniline 
leid oli muutunud tasakaal: tasakaaluhäired ja võimetus seista esines 95.3%  las-
test, millele järgnesid kõnehäired kõnehäiretest ehk „pehme keele“ esinemisest 
kuni võimetuseni kõneleda 88.7% lastest. Kõne (rs=0.16) ja teadvuse seisund 
(rs=0.13) olid parimad tunnused (p<0.0001) paigutamaks lapsed kliinilise leiu 
järgi intoksikatsiooni raskusgruppidesse. Käitumisest oli sagedamini esinevaks 
leiuks rahulikkus, loidus või pole võimalik hinnata 70.3%. 
Glükoosi tase oli negatiivses korrelatsioonis AAI lapse eaga, s.t noorematel 
lastel oli glükoosi tase kõrgem võrreldes vanemate lastega ning üldiselt oli glü-
koosi tase referentsväärtusest kõrgem 40.2% lastest. Hüperlaktineemia esines 
66% lastest ning hüpokaleemia 50% lastest, kusjuures noorematel esines hüpo-
kaleemiat vanematest lastest enam. 5 lapsel (2.6%) esines hüpokaleemia kriitili-
ses väärtuses (<2.8 mmol/l). 
Seerumi alkoholi kontsentratsioon oli noorematel tüdrukutel suurem võrrel-
des poistega, kuid vanemas eas lastel oli suhe vastupidine. Plasma laktaadi 
kontsentratsioon oli suurem kõigis alkoholi kontsentratsiooni gruppidega võr-
reldes, väljaarvatud tüdrukutel 0.2–1.49 g/L seerumi alkoholi kontsentratsiooni 
grupis. Noorematel lastel kerge negatiivne korrelatsioon SAC ja kaaliumi kont-
sentratsiooni vahel. Naatriumi tase oli veidi kõrgenenud  SAC grupis >2.50 g/L 
ja esines tugev korrelatsioon alkoholi ja naatriumi kontsentratsioonide vahel  
SAC>1.50 g/L korral.  
Östradioolil ja progesteroonil ei esinenud tugevat seost tüdrukute vanusega, 
kuid poistel esines tugev korrelatsioon testosterooni taseme ning vanuse vahel. 
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Plasma kortisooli tase korreleerus positiivselt plasma glükoosi ning laktaadi 
tasemega ja negatiivselt naatriumi tasemega.   
 
 
Järeldused 
1. Alkoholi intoksikatsiooni kliinilises hindamises oli teadvuse häirumise tase 
peamiseks diagnostiliseks tunnuseks, mis korreleerus hästi seerumi alkoholi 
kontsentratsiooniga. Kõne- ja tasakaaluhäired on sage leid alkoholi intoksikat-
siooniga lastel.    
 
2. Ägeda alkoholi intoksikatsiooni kliinilised leiud peavad olema kinnitatud 
SAC määramisega, mis on haiglates “AAI kuldseks standardiks”.  Keskmine 
tõhusus seerumi alkoholi kontsentratsiooni alusel õige AAI raskusastme diag-
noosimisel lastel oli 67.7%. Arstid hindasid kliiniliselt alkoholijoobe raskemaks 
ühe astme võrra võrreldes seerumi alkoholi kontsentratsiooniga.   
 
3. SAC/BAC suhe lastel soost ja vanusest sõltumata oli 1.19:1.   
 
4. Plasma kaaliumi, naatriumi, glükoosi ja laktaadi taset võiks hinnata kõigil 
alkoholi intoksikatsiooniga hospitaliseeritud lastel ning seerumi alkoholi kont-
sentratsiooni >1.50 g/L korral peaks biokeemiliste muutuste hindamine olema 
teostatud rutiinselt. Lastel esineva alkoholi intoksikatsiooni iseloomulikeks 
kliinilisteks tunnusteks on teadvuse häirumine ning kõne- ja tasakaaluhäired. 
Alkoholi intoksikatsiooni kliiniline leid lastel võib olla ühe astme võrra raskem 
võrreldes seerumi alkoholi kontsentratsioonist lähtuva alkoholijoobe raskus-
astmega võrreldes. Hüperlaktineemia, hüpokaleemia ja kõrgenenud glükoosi 
tase on sage biokeemiline leid ägeda alkoholi intoksikatsiooniga hospitalisee-
ritud lastel. Hüpoglükeemia leid oli harvaesinev. Biokeemilised muutused esi-
nevad paralleelselt kõigi seerumi alkoholi kontsentratsioonide korral, kuid 
märkimisväärsed muutused on nähtavad SAC üle 1.50 g/L korral.   
 
5. Suurenenud plasma kortisooli tase üle referentsväärtuse on AAI lastel sage 
leid. Kortisool korreleerus positiivselt plasma glükoosi tasemega ning tüdru-
kutel progesterooni kontsentratsiooniga.  
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Medical Assessment Form No … 
1) Medical history no  ............................................................................................ 
2) Age or date of birth  ........................................................................................... 
3) Sex:   M      W (menses not started, last menses  ............................................. ) 
4) Assessment date and time  ................................................................................. 
5) Paediatrician´s name  ......................................................................................... 
 
Examined child  
1) Appearance: clear; dirty; injuries  ...................................................................... 
 ................................................................................................................................ 
2) Behaviour:  
normal; aggressiveness; euphoria; restful; apathy; impossible assess 
3) Consciousness:  
clear; disorientation; euphoria; somnolence; stupor;  
coma (GCS ………… points) 
4) Memory about last hours:   clear; partly; absent 
5) Other health problems:  
 ................................................................................................................................ 
6) Redness of face; redness of conjunctives;    
7) Body temperature: ………… 0C; sweating:   yes; no 
8) Heart rate ………… beats per minute 
9) Blood pressure ………… mm Hg 
10) Respiration rate: ………… per minute 
11) Speech:   normal; rushed; fast; confused; unable to speak 
12) Pupils size:   normal; dilated; narrowed 
reaction to light:   normal; tardy; absent 
13) Nystagmus:   no; horizontal; vertical; mixed type 
14) Balance:   normal; imbalanced; unable to stand 
15) Muscle tone:   normal; decreased; increased  
16) Consumed alcohol: amount ………… Firstly; repeatedly 
  Date of consumption  ....................................................... 
  Time of consumption  ....................................................... 
17) Results of laboratory tests 
Glucose …………… mmol/l K+ ……………. mmol/l 
Lactate ……………. mmol/l Na+ …………… mmol/l 
Ethanol ……………. mg/dl 
18) Estimating of the severity of AAI: sober; mild; moderate; severe 
 
Blood! Urine! 
 
 
 
 
Addendum 1. Medical Assessment Form 
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PROTOKOLL Nr … 
1) Haiguslugu / sissekanne nr  ................................................................................ 
2) Vanus või sünniaeg  ........................................................................................... 
3) Sugu:   M      N (menses puudub,  viimane menses  ........................................ ) 
4) Läbivaatuse kuupäev ja kellaaeg  ....................................................................... 
5) Läbivaatuse teostanud arst  ................................................................................ 
 
Uuritava 
1) välimus:   puhas,  määrdunud,  välised vigastused  ............................................ 
 ................................................................................................................................ 
2) käitumine: tavaline,  agressiivne,  eufooriline,  rahulik,  loid, pole hinnatav 
3) teadvus: selge,  düsorienteeritud,  eufooriline,  somnolentsus,  stuupor, 
kooma (GKS ……… punkti) 
4) mälu viimaste tundide kohta:   olemas,  osaline,  puudub 
5) kaasnevad haigused:  
 ................................................................................................................................ 
6) näo punetus; silmade sidekestade punetus;    
7) kehatemperatuur: ……… 0C;    higistamine:   esineb, ei esine 
8) pulss ……… korda minutis 
9) vererõhk ……… mm Hg 
10) hingamissagedus: ……… korda minutis 
11) kõne:   aeglane,  kiire,  segane,  puudub 
12) pupillid suurus:   normis;  laienenud;  ahenenud   
reaktsioon valgusele:   normis;  aeglustunud; puudub 
13) nüstagm:   ei esine; esineb horisontaalne,  vertikaalne, segatüüp 
14) tasakaal:   normis, häirunud, pole hinnatav 
15) lihastoonus:   normis, alanenud, suurenenud  
16) ütlused alkoholi tarvitamise kohta: kogus ………… esmakordne,  korduv 
  tarvitamise kuupäev  ............................... 
  tarvitamise kellaaeg  ............................... 
17) laboratoorsete uuringute tulemused 
glükoos ………… mmol/l K+ ………….. mmol/l 
laktaat ………….. mmol/l Na+ ………… mmol/l 
etanool …………. mg/dl 
18) arsti otsus joobeastme kohta:   joovet ei esine,  kerge,  keskmine,  raske 
 
Veri! Uriin! 
 
 
 
 
 
 
Lisa 1. Meditsiinilise läbivaatuse vorm.  
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